Treatment Efficacy Studies in Myanmar
Treatment Efficacy Studies are conducted routinely in Myanmar, to assess the efficacy of frontline treatments. Dried bloodspot (DBS) samples for this study were collected from patients at multiple sites from 2012, and the patient clinical parasite clearance phenotypes are recorded. In this collaboration, we genotyped parasite DNA samples to establish the prevalence of drug resistance mutations and genetic backgrounds, and associate genetic variations to phenotypes.
Summary
- 158 Samples
- 2 Locations
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Locations
Sagaing
Summary
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Shan
Summary
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers